Incretin-Targeting Technologies for Type 2 Diabetes: Dipeptidyl Peptidase IV Inhibitors and Glucagon-Like Peptide-1 Analogs
Author： Adis International Limited
Publisher： Adis International
ISSN： 1176-3469
Source： Pharmaceutical & Diagnostic Innovation, Vol.4, Iss.7, 2006-07, pp. : 3-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
